
NMAD Market Capitalization Overview
Market Cap: $127.62M as of Jul 6, 2026
$127.62M
$40.94M (47.23%)past month
As of Jul 6, 2026, NMAD has a market capitalization of $127.62M. Over the past 30 days, its market cap has increased by 49.37%, while in the last 12 months, it has increased by 305.75%.
Market capitalization represents the total value of Lixte Biotechnology Holdings I as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
NMAD Market Cap Formula = Stock Price * Shares Outstanding
The market cap of NMADhelps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Lixte Biotechnology Holdings I as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
NMAD Market Cap Formula = Stock Price * Shares Outstanding
The market cap of NMADhelps investors assess the company's size and compare it with competitors for better investment decisions.
NMAD Market Cap & Key Trends
See Lixte Biotechnology Holdings I’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in NMAD
Order type
Buy in
Order amount
Est. shares
0 shares
NMAD Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Jul 1, 2026 | $133.36M | +49.37% |
| Jun 1, 2026 | $89.29M | +128.03% |
| May 1, 2026 | $39.16M | +59.43% |
| Apr 1, 2026 | $24.56M | +4.61% |
| Mar 2, 2026 | $23.48M | -17.60% |
| Feb 2, 2026 | $28.50M | -7.29% |
| Jan 2, 2026 | $30.74M | +31.40% |
NMAD End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $127.62M | +305.75% |
| 2025 | $31.46M | +588.92% |
| 2024 | $4.57M | -13.63% |
| 2023 | $5.29M | -37.62% |
| 2022 | $8.48M | -48.20% |
| 2021 | $16.36M | — |
FAQs About Lixte Biotechnology Holdings I (NMAD) Market Cap
As of Jul 6, 2026, the market capitalization of NMAD is $127.62M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Lixte Biotechnology Holdings I’s market capitalization has increased by 47.23%, changing from $86.69M to $127.62M as of Jul 6, 2026.
In the last 3 months, Lixte Biotechnology Holdings I’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Lixte Biotechnology Holdings I’s market capitalization increased from $4.57M in January to $31.46M in December, reflecting a 588.92% change.
In the past five years, NMAD has had a compound annual growth rate (CAGR) of 13.97% in market capitalization. This means its market cap has grown at an average rate of 13.97% per year.